Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 2
Neurology® Podcast
In the second part of this two-part series, Dr. Robert Holloway talks with Dr. Carolyn Rennels about legal and ethical considerations, the importance of interdisciplinary support, and the emotional impact on clinicians. Read the related article in . Disclosures can be found at .
info_outline
Characteristics and Motivations of People With ALS Who Pursue Medical Aid in Dying - Part 1
Neurology® Podcast
In the first part of this two-part series, Dr. Robert Holloway talks with Dr. Carolyn Rennels about the background of the study, the definition and practice of MAID, and the main reasons that lead ALS patients to consider it. Read the related article in . Disclosures can be found at .
info_outline
Outcomes Following Acute Plasma Exchange for MOGAD
Neurology® Podcast
Dr. Justin Abbatemarco talks with Drs. John Chen and Smathorn Thakolwiboon about the outcomes following plasma exchange in MOGAD and explore how the findings from this study can inform patient care. Read the related article in . Disclosures can be found at .
info_outline
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 2
Neurology® Podcast
In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about overcoming funding challenges, the importance of rigor and reputation, unmet needs in neurology, and leveraging AI in neurology research. Disclosures can be found at .
info_outline
Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 1
Neurology® Podcast
In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about recent advancements in neurology, emerging genomic therapies, the evolving understanding of long COVID, and current NINDS priorities. Disclosures can be found at .
info_outline
Updates on All Things Myositis – Part 2
Neurology® Podcast
In part two of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about treatment options, real-world case studies, and future directions in myositis research. Disclosures can be found at .
info_outline
Updates on All Things Myositis – Part 1
Neurology® Podcast
In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Andrew Mammen about the different types of myositis, approaches to diagnosis, available diagnostic tools, and the evolving roles of MRI and biopsy in clinical practice. Disclosures can be found at .
info_outline
September 2025 Recall: Topics on Epilepsy
Neurology® Podcast
The September 2025 Recall replay highlights four previously released episodes focused on epilepsy. Dr. Halley Alexander begins the series with Dr. Juan Luis Alcala-Zermeno, discussing outcomes of epilepsy surgery in patients with tonic-clonic seizures. She then speaks with Dr. Samuel W. Terman about patients’ perceived seizure risk, seizure risk tolerance, and approaches to risk counseling. In the third episode, Dr. Alexander is joined by Dr. Vineet Punia to explore factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized...
info_outline
GLP-1RA–Associated Diabetic Lumbosacral Radiculoplexus and Common Fibular Neuropathies
Neurology® Podcast
Dr. Alex Menze talks with Dr. Christopher J. Klein about the clinical presentation, diagnosis, and management of diabetic lumbosacral radiculoplexus neuropathy and common fibular neuropathy in the context of GLP-1RA. Read the related article in . Disclosures can be found at .
info_outline
Stability and Accuracy of a Diagnosis of Parkinson Disease Over 10 Years
Neurology® Podcast
Dr. Jeff Ratliff talks with Dr. Valtteri Kaasinen about the clinical challenges of diagnosing Parkinson disease and how that diagnosis can evolve over time. Read the related article in . Disclosures can be found at .
info_outlineThe May 2025 recall features four previously posted episodes on myasthenia gravis. The first episode has Dr. Fredrik Piehl discussing rituximab for new-onset generalized MG. In the second episode, Dr. Vera Bril explores the potential use of immunoglobulin as a corticosteroid-sparing agent in MG patients. The third episode features Dr. Ali A. Habib discussing trends in hospital admissions and in-hospital mortality for adult MG patients. The series concludes with Dr. Jennifer Morganroth addressing the increase in thymectomy procedures post-MGTX trial, disparities in access to these surgeries among different demographic groups, and the rise of minimally invasive surgical techniques.
Podcast links:
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
Hospitalizations and Mortality from MG Hospitalizations and Mortality From Myasthenia Gravis
Trends and Disparities in the Utilization of Thymectomy for MG in the US
Article links:
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis
Hospitalizations and Mortality From Myasthenia Gravis
Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States
Disclosures can be found at Neurology.org.